Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/1932296820964264 http://scihub22266oqcxt.onion/10.1177/1932296820964264 33063556!7645121!33063556     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Diabetes+Sci+Technol 2020 ; 14 (6): 1065-1073 Nephropedia Template TP {{tp|p=33063556|t=2020. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study |pdf=|usr=}}{{33063556}} gab.com Text Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study JO: J Diabetes Sci Technol http://www.kidney.de/pget.php?&tw=1&pmid=33063556 #FOAvip BACKGROUND: Amidst the coronavirus disease 2019 (COVID-19) pandemic, continuous glucose monitoring (CGM) has emerged as an alternative for inpatient point-of-care blood glucose (POC-BG) monitoring. We performed a feasibility pilot study using CGM in critically ill patients with COVID-19 in the intensive care unit (ICU). METHODS: Single-center, retrospective study of glucose monitoring in critically ill patients with COVID-19 on insulin therapy using Medtronic Guardian Connect and Dexcom G6 CGM systems. Primary outcomes were feasibility and accuracy for trending POC-BG. Secondary outcomes included reliability and nurse acceptance. Sensor glucose (SG) was used for trends between POC-BG with nursing guidance to reduce POC-BG frequency from one to two hours to four hours when the SG was in the target range. Mean absolute relative difference (MARD), Clarke error grids analysis (EGA), and Bland-Altman (B&A) plots were calculated for accuracy of paired SG and POC-BG measurements. RESULTS: CGM devices were placed on 11 patients: Medtronic (n = 6) and Dexcom G6 (n = 5). Both systems were feasible and reliable with good nurse acceptance. To determine accuracy, 437 paired SG and POC-BG readings were analyzed. For Medtronic, the MARD was 13.1% with 100% of readings in zones A and B on Clarke EGA. For Dexcom, MARD was 11.1% with 98% of readings in zones A and B. B&A plots had a mean bias of -17.76 mg/dL (Medtronic) and -1.94 mg/dL (Dexcom), with wide 95% limits of agreement. CONCLUSIONS: During the COVID-19 pandemic, CGM is feasible in critically ill patients and has acceptable accuracy to identify trends and guide intermittent blood glucose monitoring with insulin therapy. Twit Text FOAVip Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study ????J Diabetes Sci Technol http://www.kidney.de/pget.php?&tw=1&pmid=33063556 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33063556 #FOAvip English Wikipedia <ref>{{Cite pmid|33063556}}</ref> Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study #MMPMID33063556 Sadhu AR; Serrano IA; Xu J; Nisar T; Lucier J; Pandya AR; Patham B J Diabetes Sci Technol 2020[Nov]; 14 (6): 1065-1073 PMID33063556show ga BACKGROUND: Amidst the coronavirus disease 2019 (COVID-19) pandemic, continuous glucose monitoring (CGM) has emerged as an alternative for inpatient point-of-care blood glucose (POC-BG) monitoring. We performed a feasibility pilot study using CGM in critically ill patients with COVID-19 in the intensive care unit (ICU). METHODS: Single-center, retrospective study of glucose monitoring in critically ill patients with COVID-19 on insulin therapy using Medtronic Guardian Connect and Dexcom G6 CGM systems. Primary outcomes were feasibility and accuracy for trending POC-BG. Secondary outcomes included reliability and nurse acceptance. Sensor glucose (SG) was used for trends between POC-BG with nursing guidance to reduce POC-BG frequency from one to two hours to four hours when the SG was in the target range. Mean absolute relative difference (MARD), Clarke error grids analysis (EGA), and Bland-Altman (B&A) plots were calculated for accuracy of paired SG and POC-BG measurements. RESULTS: CGM devices were placed on 11 patients: Medtronic (n = 6) and Dexcom G6 (n = 5). Both systems were feasible and reliable with good nurse acceptance. To determine accuracy, 437 paired SG and POC-BG readings were analyzed. For Medtronic, the MARD was 13.1% with 100% of readings in zones A and B on Clarke EGA. For Dexcom, MARD was 11.1% with 98% of readings in zones A and B. B&A plots had a mean bias of -17.76 mg/dL (Medtronic) and -1.94 mg/dL (Dexcom), with wide 95% limits of agreement. CONCLUSIONS: During the COVID-19 pandemic, CGM is feasible in critically ill patients and has acceptable accuracy to identify trends and guide intermittent blood glucose monitoring with insulin therapy. |Adult[MESH] |Aged[MESH] |Betacoronavirus/physiology[MESH] |Blood Glucose Self-Monitoring/instrumentation/methods[MESH] |Blood Glucose/*analysis/metabolism[MESH] |COVID-19[MESH] |Coronavirus Infections/*blood/epidemiology/mortality/*therapy[MESH] |Critical Illness/epidemiology/mortality/*therapy[MESH] |Diabetes Mellitus/blood/diagnosis/mortality/therapy[MESH] |Feasibility Studies[MESH] |Female[MESH] |Humans[MESH] |Hyperglycemia/blood/diagnosis/mortality/therapy[MESH] |Insulin Infusion Systems[MESH] |Insulin/administration & dosage[MESH] |Intensive Care Units[MESH] |Male[MESH] |Middle Aged[MESH] |Monitoring, Physiologic/*instrumentation/methods[MESH] |Pandemics[MESH] |Pilot Projects[MESH] |Pneumonia, Viral/*blood/epidemiology/mortality/*therapy[MESH] |Point-of-Care Systems[MESH] |Prognosis[MESH] |Reproducibility of Results[MESH] |Retrospective Studies[MESH]Continuous Glucose Monitoring in Critically Ill Patients With COVID-19(epmc).pdf DeepDyve Pubget Overpricing